Compare Medpace Holdings Inc (MEDP) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs US Bancorp — how do they compare? Medpace Holdings Inc trades at $609.54 (market cap $16.90B), while US Bancorp trades at $64.34 (market cap $100.17B). The key difference: US Bancorp is far larger — about 5.9× Medpace Holdings Inc's market cap, and US Bancorp pays a 3.24% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | USB | |
|---|---|---|
Market Cap | $16.90B | $100.17B |
Sector | Technology | Financials |
52-Week High | $620.59 | $64.47 |
52-Week Low | $393.42 | $45.28 |
Enterprise Value | $16.52B | — |
Dividend Yield | — | 3.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
